Drug Shortage Report for MINT-OLANZAPINE
Report ID | 122524 |
Drug Identification Number | 02410168 |
Brand name | MINT-OLANZAPINE |
Common or Proper name | Olanzapine |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottles |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-08-19 |
Actual start date | |
Estimated end date | 2020-09-30 |
Actual end date | 2020-10-26 |
Shortage status | Resolved |
Updated date | 2020-10-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-10-27 | French | Compare |
v6 | 2020-10-27 | English | Compare |
v5 | 2020-09-21 | French | Compare |
v4 | 2020-09-21 | English | Compare |
v3 | 2020-08-20 | English | Compare |
v2 | 2020-08-19 | French | Compare |
v1 | 2020-08-19 | English | Compare |
Showing 1 to 7 of 7